These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7510616)

  • 41. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of acid-related disorders in the United States.
    Brown M; Yang RD
    Manag Care; 2001 Oct; 10(10 Suppl):7-10. PubMed ID: 11729446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Policy analysis of the conversion of histamine2 antagonists to over-the-counter use.
    Kalish SC; Bohn RL; Avorn J
    Med Care; 1997 Jan; 35(1):32-48. PubMed ID: 8998201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The place of histamine H2 receptor antagonists in the treatment of diseases of the gastrointestinal tract].
    Visnovský P; Valentík M
    Cesk Gastroenterol Vyz; 1979 Jul; 33(5):312-5. PubMed ID: 41642
    [No Abstract]   [Full Text] [Related]  

  • 45. Histamine-2-receptor antagonists in gastro-oesophageal reflux.
    Colin-Jones DG
    Gut; 1989 Oct; 30(10):1305-8. PubMed ID: 2573565
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treating gastroesophageal reflux disease.
    Long K; Long R
    Nurse Pract Forum; 1994 Jun; 5(2):63-4. PubMed ID: 7912126
    [No Abstract]   [Full Text] [Related]  

  • 48. Nonprescription H2-receptor antagonists.
    Marsh TD
    J Am Pharm Assoc (Wash); 1997; NS37(5):552-6. PubMed ID: 9479407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bone up on proton pump inhibitors and fracture risk.
    Gendreau-Webb R
    Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
    [No Abstract]   [Full Text] [Related]  

  • 50. H2-receptor antagonists in the treatment of complicated gastroesophageal reflux disease: "for whom the bell tolls".
    Fennerty MB; Lieberman D
    Gastroenterology; 1994 Nov; 107(5):1545-8. PubMed ID: 7926519
    [No Abstract]   [Full Text] [Related]  

  • 51. Gastroesophageal reflux disease. The long and the short of therapeutic options.
    Brady WM; Ogorek CP
    Postgrad Med; 1996 Nov; 100(5):76-80, 85-6, 89. PubMed ID: 8917326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-reported effectiveness and physician consultation rate in users of over-the-counter histamine-2 receptor antagonists.
    Shaw MJ; Fendrick AM; Kane RL; Adlis SA; Talley NJ
    Am J Gastroenterol; 2001 Mar; 96(3):673-6. PubMed ID: 11280532
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
    Leite LP; Just RJ; Castell DO; Lagerström PO
    Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.
    Deakin M; Williams JG
    Drugs; 1992 Nov; 44(5):709-19. PubMed ID: 1280563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The medical management of reflux esophagitis. Role of antacids and acid inhibition.
    Sontag SJ
    Gastroenterol Clin North Am; 1990 Sep; 19(3):683-712. PubMed ID: 1977703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 58. Gastroesophageal reflux: medical and surgical treatment options.
    DeVault KR
    Am Fam Physician; 2003 Oct; 68(7):1271, 1274, 1277. PubMed ID: 14567483
    [No Abstract]   [Full Text] [Related]  

  • 59. [H2-blockers in the pediatric practice: is the potential exhausted?].
    Bel'mer SV; Kovalenko AA; Gasilina TV
    Eksp Klin Gastroenterol; 2005; (6):19-22. PubMed ID: 17378381
    [No Abstract]   [Full Text] [Related]  

  • 60. Drugs for peptic ulcer disease and GERD.
    Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.